Eli Lilly Corp. buy Guggenheim
Start price
16.10.25
/
50%
€710.00
Target price
16.10.26
€812.06
Performance (%)
50.25%
Price
10:39
€1,066.8
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Eli Lilly Corp. has seen massive gains of 50.25%. This prediction currently runs until 16.10.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 9.496% | 9.496% |
| iShares Core DAX® | 1.001% | 4.831% |
| iShares Nasdaq 100 | 2.702% | -1.720% |
| iShares Nikkei 225® | 3.519% | -3.506% |
| iShares S&P 500 | 1.766% | 1.273% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $948.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
54.93%
12.07.26
12.07.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€662.90
20.06.25
20.06.25
€813.01
20.06.26
20.06.26
45.32%
21.06.26
21.06.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.40
14.04.25
14.04.25
€814.97
14.04.26
14.04.26
19.47%
15.04.26
15.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25